Wendall Wierenga, Director at APRICUS BIOSCIENCES, INC. (APRI), bought 20,000 shares at $1.52 ($30K) on 2014-10-22, disclosed to the SEC on 2014-10-24.
Open-market purchase of $30k APRI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2024-11-26 | $37K | — | Filing → |
| CYTK | SELL | 2024-10-31 | $233K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |